<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516461</url>
  </required_header>
  <id_info>
    <org_study_id>SMT-YJ-201702</org_study_id>
    <nct_id>NCT03516461</nct_id>
  </id_info>
  <brief_title>Microbiota Transplantation for Radiation Enteritis</brief_title>
  <official_title>Efficacy and Safety of Selective Microbiota Transplantation and Fecal Microbiota Transplantation in Radiation Enteritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fuzhou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiation enteritis is one of the most feared complications after abdominal or pelvic
      radiation therapy.The gut microbiota is considered to constitute a &quot;microbial organ&quot; which
      has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal
      studies demonstrated the link between intestinal bacteria and radiation enteritis. This
      clinical trial aims to evaluate the efficacy and safety of selective microbiota
      transplantation (SMT) and fecal microbiota transplantation (FMT) for radiation enteritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present clinical trial aims to re-establish a gut functionality state of intestinal flora
      through selective microbiota transplantation (SMT) or fecal microbiota transplantation (FMT)
      for radiation enteritis (RE). FMT is the whole profile of fecal microbiota transplantation.
      SMT is the intermediate composition of bacteria between traditional probiotics and whole
      profile of microbiota; it aims to stimulate the efficiency of fecal microbiota
      transplantation. At enrollment, &quot;Shared Decision Making&quot; intervention was applied to support
      patient involvement in making health decisions. Patients have opportunity to choose selective
      microbiota transplantation (SMT) or fecal microbiota transplantation (FMT). Patients will
      receive follow-up for at least 4 weeks. Blood test, endoscopy and questionnaire will be used
      to access participants at study start and at study completion. Fecal microbiota compositions,
      blood and urinary metabolic profiles of patients will be analyzed to assess associated
      microbial changes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of toxicity grade</measure>
    <time_frame>4 weeks</time_frame>
    <description>The change of toxicity grade according to the RTOG/EORTC toxicity scale at 4 weeks after SMT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Scores of gastrointestinal symptoms</measure>
    <time_frame>4 weeks</time_frame>
    <description>Gastrointestinal symptoms will be evaluated according to NCI-CTC 5.0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Karnofsky Performance Status (KPS) scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in functional status of patients will be assessed according to the Karnofsky Performance Status (KPS) scale (ranging from 0 [dead] to 100 [normal activity, no evidence of disease])</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Radiation Enteritis</condition>
  <arm_group>
    <arm_group_label>Selective Microbiota Transplant (SMT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo once SMT a day for three consecutive days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fecal Microbiota Transplantation (FMT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo FMT on day 1. If they fail to benefit from single FMT, repeat FMTs (no more than 3 times) would be performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Selective Microbiota Transplantation (SMT)</intervention_name>
    <description>Selective microbiota transplantation for patients via nasointestinal tube (once per day for 3 days)</description>
    <arm_group_label>Selective Microbiota Transplant (SMT)</arm_group_label>
    <other_name>SMT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fecal Microbiota Transplantation (FMT)</intervention_name>
    <description>Fecal microbiota transplantation for patients via nasointestinal tube or gastroscopy (once per day and no more than 3 times)</description>
    <arm_group_label>Fecal Microbiota Transplantation (FMT)</arm_group_label>
    <other_name>FMT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age ≥18 years old;

          2. Radiation enteritis diagnosed by colonoscopy after finishing radiotherapy.

        Exclusion Criteria:

          1. Patients who were pregnant or nursing;

          2. Patients who were unable or unwilling to undergo a gastroscopy;

          3. Patients who had gastrointestinal infection;

          4. Patients with cardiopulmonary failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faming Zhang, MD; PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faming Zhang, MD; PHD</last_name>
    <phone>086-25-58509883</phone>
    <email>fzhang@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faming Zhang, MD, PhD</last_name>
      <phone>086-25-58509883</phone>
      <email>fzhang@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, Zheng Q, Dong J, Zhao Y, Zhang X, Zhang J, Lu L, Wang H, Fan S. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. 2017 Apr;9(4):448-461. doi: 10.15252/emmm.201606932.</citation>
    <PMID>28242755</PMID>
  </reference>
  <reference>
    <citation>Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):88-96. doi: 10.1038/nrgastro.2011.244. Review.</citation>
    <PMID>22183182</PMID>
  </reference>
  <reference>
    <citation>Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015 Jan;30(1):51-8. doi: 10.1111/jgh.12727.</citation>
    <PMID>25168749</PMID>
  </reference>
  <reference>
    <citation>Ferreira MR, Muls A, Dearnaley DP, Andreyev HJ. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncol. 2014 Mar;15(3):e139-47. doi: 10.1016/S1470-2045(13)70504-7. Review.</citation>
    <PMID>24599929</PMID>
  </reference>
  <reference>
    <citation>Zhang F, Cui B, He X, Nie Y, Wu K, Fan D; FMT-standardization Study Group. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018 May;9(5):462-473. doi: 10.1007/s13238-018-0541-8. Epub 2018 Apr 24. Review.</citation>
    <PMID>29691757</PMID>
  </reference>
  <reference>
    <citation>Manichanh C, Varela E, Martinez C, Antolin M, Llopis M, Doré J, Giralt J, Guarner F, Malagelada JR. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol. 2008 Jul;103(7):1754-61. doi: 10.1111/j.1572-0241.2008.01868.x. Epub 2008 Jun 28.</citation>
    <PMID>18564125</PMID>
  </reference>
  <reference>
    <citation>Wang A, Ling Z, Yang Z, Kiela PR, Wang T, Wang C, Cao L, Geng F, Shen M, Ran X, Su Y, Cheng T, Wang J. Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One. 2015 May 8;10(5):e0126312. doi: 10.1371/journal.pone.0126312. eCollection 2015.</citation>
    <PMID>25955845</PMID>
  </reference>
  <reference>
    <citation>Kim YS, Kim J, Park SJ. High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. Anaerobe. 2015 Jun;33:1-7. doi: 10.1016/j.anaerobe.2015.01.004. Epub 2015 Jan 16.</citation>
    <PMID>25600706</PMID>
  </reference>
  <reference>
    <citation>Delia P, Sansotta G, Donato V, Messina G, Frosina P, Pergolizzi S, De Renzis C, Famularo G. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol. 2002 Aug;97(8):2150-2.</citation>
    <PMID>12190202</PMID>
  </reference>
  <reference>
    <citation>Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr. 2014 Oct;33(5):761-7. doi: 10.1016/j.clnu.2013.10.015. Epub 2013 Oct 24.</citation>
    <PMID>24200199</PMID>
  </reference>
  <reference>
    <citation>Nascimento M, Aguilar-Nascimento JE, Caporossi C, Castro-Barcellos HM, Motta RT. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):289-95. doi: 10.1016/j.ijrobp.2014.05.049.</citation>
    <PMID>25304789</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>January 7, 2018</study_first_submitted>
  <study_first_submitted_qc>May 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Faming Zhang</investigator_full_name>
    <investigator_title>Associate professor, Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Gut Microbiota</keyword>
  <keyword>Radiation Enteritis</keyword>
  <keyword>Selective Microbiota Transplantation</keyword>
  <keyword>Fecal Microbiota Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enteritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

